Sarepta Therapeutics (SRPT) Invested Capital (2010 - 2025)
Sarepta Therapeutics (SRPT) posted quarterly Invested Capital of $36.0 million for Q3 2025, down 60.7% year-over-year from $91.6 million in Q3 2024, and down 60.7% quarter-over-quarter from $91.6 million in Q3 2024.
Sarepta Therapeutics (SRPT) Invested Capital (2010 - 2025) Analysis & Trends
Sarepta Therapeutics' Invested Capital history runs 12 years deep, the most recent figure standing at $36.0 million for Q3 2025.
- In Q3 2025, Invested Capital fell 60.7% year-over-year to $36.0 million; the TTM figure through Mar 2026 stood at $36.0 million (down 80.34% YoY), while the FY2023 annual figure was $105.5 million, changed N/A from the prior year.
- Invested Capital for Q3 2025 stood at $36.0 million, down from $91.6 million in the prior quarter.
- The five-year high for Invested Capital was $105.6 million in Q1 2024, with the low at $36.0 million in Q3 2025.
- The 3-year median for Invested Capital is $91.6 million (2024), against an average of $86.0 million.
- Peak annual rise in Invested Capital reached 60.7% in 2025, while the deepest fall reached 60.7% in 2025.
- Sarepta Therapeutics' Invested Capital stood at $105.5 million in 2023, then declined by 13.17% to $91.6 million in 2024, then tumbled by 60.7% to $36.0 million in 2025.
- Business Quant data shows SRPT's Invested Capital at $36.0 million in Q3 2025, $91.6 million in Q3 2024, and $91.5 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2024 | 91.60 Mn |
| Jun 30, 2024 | 91.51 Mn |
| Mar 31, 2024 | 105.59 Mn |
| Dec 31, 2023 | 105.48 Mn |
| Jun 30, 2018 | 9.51 Mn |
| Mar 31, 2018 | 3.45 Mn |
| Dec 31, 2017 | 6.18 Mn |
| Sep 30, 2017 | 4.73 Mn |
| Jun 30, 2017 | 11.22 Mn |
| Mar 31, 2017 | 11.35 Mn |
| Dec 31, 2016 | 10.11 Mn |
| Sep 30, 2016 | 10.11 Mn |
| Jun 30, 2016 | 10.11 Mn |
| Mar 31, 2016 | 7.60 Mn |
| Dec 31, 2015 | 5.94 Mn |
| Sep 30, 2015 | 3.44 Mn |
| Jun 30, 2015 | 100,000.00 |
| Mar 31, 2015 | 99,000.00 |
| Dec 31, 2014 | 98,000.00 |